This isn’t news. And it’s certainly not price sensitive news. The market has known for long time OSL would file in multiple places on back of CE, including Australia.
What would have been real news is for the company to have released updated trial results following the presentation which was given yesterday at the European GI cancers conference which means it’s public . OSL hasn’t updated market now for a year now and still using results from last June. Why will it not give the market an update? It’s not a good look.
This isn’t news. And it’s certainly not price sensitive news....
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.01 |
Change
-0.025(2.43%) |
Mkt cap ! $14.29M | |||
| Open | High | Low | Value | Volume |
| $1.04 | $1.05 | $1.00 | $41.05K | 40.86K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $1.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.05 | 1249 | 1 |
View Market Depth
| Last trade - 15.47pm 20/06/2025 (20 minute delay) ? |
| OSL (ASX) Chart |